Showing results (111-120 of 136) with videos related to
Sort By:
Pageof 14
Molecular and Cellular Biology|December 1, 1996
Cdc53p acts in concert with Cdc4p and Cdc34p to control the G1-to-S-phase transition and identifies a conserved family of proteinsN Mathias, S L Johnson, M Winey, et al.Immunotechnology : an International Journal of Immunological Engineering|May 7, 1999
An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G proteinM Hansson, J Ringdahl, A Robert, et al.Journal of Animal Science|August 11, 1992
Digestion, feed intake, and live weight gain by cattle consuming bermudagrass hay supplemented with wheyD L Galloway, A L Goetsch, W Sun, et al.Journal of Animal Science|February 1, 1991
Effects of animal and supplement characteristics on average daily gain of grazing beef cattleA L Goetsch, G E Murphy, E W Grant, et al.Prenatal Diagnosis|July 20, 2020
Impact of cell-free DNA screening on parental knowledge of fetal sex and disorders of sex developmentLaurel Sofer, Anthony D'Oro, Ilina Rosoklija, et al.Journal of Animal Science|March 13, 2012
Effects of different fresh-cut forages and their hays on feed intake, digestibility, heat production, and ruminal methane emission by Boer x Spanish goatsR Puchala, G Animut, A K Patra, et al.Journal of Pediatric and Adolescent Gynecology|August 30, 2019
Turner Syndrome with Y Chromosome: Spontaneous Thelarche, Menarche, and Risk of MalignancyElizabeth Dabrowski, Emilie K Johnson, Vrunda Patel, et al.Archiv Fur Tierernahrung|January 1, 1993
Effects of various supplements on voluntary intake and performance by growing cattle consuming forage moderate to high in crude proteinA L Goetsch, D L Galloway, L A Forster, et al.Vaccine|April 27, 2000
Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidateL Goetsch, H Plotnicky-Gilquin, T Champion, et al.Biologicals : Journal of the International Association of Biological Standardization|February 20, 2002
Stability and CTL-activity of P40/ELA melanoma vaccine candidateA Beck, L Goetsch, T Champion, et al.Pageof 14